Aphria Q3 2019 Earnings Review – Headlines Create Opportunity
Aphria (TSE: APHA) posted messy quarterly results but remains an undervalued name with big revenue potential later in 2019.
HEXO
Organigram 2Q 2019 Earnings Review – Selling Cannabis Customers Want
Organigram (CVE: OGI) posted another strong revenue growth quarter. As a smaller producer, their cannabis production capabilities are impressive and undervalued.
Canadian Cannabis Scorecard (Spring 2019)
Confused about which marijuana stocks are worth your money? The cannabis scorecard is your guide to separating the best from the worst.
HEXO Completes First Harvest At 1,000,000 Sq. Ft. Greenhouse
After months of construction in a major expansion, the Gatineau facility from HEXO Corp (TSX:HEXO; NYSE-A:HEXO) is now harvesting...
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (March 16th, 2019)
A weekly review of the most important cannabis news affecting marijuana investors' portfolios. Includes legalization updates, earnings reports,...
HEXO Q2 2019 Earnings – On the Edge of Profitability
A full review of HEXO Q2 2019 earnings. Should you buy this value priced name or are there better cannabis options out there?
HEXO Corp Enters Agreement to Acquire Newstrike Brands
The $273 million all stock deal will see HEXO Corp (TSX: HEXO; NYSE-A: HEXO) acquiring all outstanding shares...
Canopy Growth Q2 2019 Earnings Review – Big Growth With a Big Cost Structure to Match
Will Canopy Growth's (TSE: WEED; NYSE: CGC) earnings drive the sector to new highs or will results throw...
Aurora Cannabis Q2 2019 Earnings Review – Recreational Ramp Slower Than Expected
Based on Aurora's results, investors may have to wait until 2020 for cannabis stocks to generate any earnings...